Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetics and Antifungal Activity of Echinocandins in Ascites Fluid of Critically Ill Patients.
Welte R, Oberacher H, Gasperetti T, Pfisterer H, Griesmacher A, Santner T, Lass-Flörl C, Hörtnagl C, Leitner-Rupprich S, Aigner M, Lorenz I, Schmid S, Edlinger M, Eller P, Dankl D, Joannidis M, Bellmann R. Welte R, et al. Among authors: aigner m. Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0256520. doi: 10.1128/AAC.02565-20. Epub 2021 Jun 17. Antimicrob Agents Chemother. 2021. PMID: 33972242 Free PMC article.
Biliary amphotericin B pharmacokinetics and pharmacodynamics in critically ill liver transplant recipients receiving treatment with amphotericin B lipid formulations.
Welte R, Eschertzhuber S, Weiler S, Leitner-Rupprich S, Aigner M, Lass-Flörl C, Stienecke E, Bellmann-Weiler R, Joannidis M, Bellmann R. Welte R, et al. Among authors: aigner m. Int J Antimicrob Agents. 2015 Sep;46(3):325-31. doi: 10.1016/j.ijantimicag.2015.04.009. Epub 2015 Jun 2. Int J Antimicrob Agents. 2015. PMID: 26119497 Free article.
Penetration of echinocandins into wound secretion of critically ill patients.
Gasperetti T, Welte R, Oberacher H, Marx J, Lorenz I, Schellongowski P, Staudinger T, Burgmann K, Eller P, Santner T, Griesmacher A, Pfisterer H, Eschertzhuber S, Aigner M, Joannidis M, Bellmann R. Gasperetti T, et al. Among authors: aigner m. Infection. 2021 Aug;49(4):747-755. doi: 10.1007/s15010-021-01604-x. Epub 2021 Apr 20. Infection. 2021. PMID: 33877638 Free PMC article.
Caspofungin: when and how? The microbiologist's view.
Mayr A, Aigner M, Lass-Flörl C. Mayr A, et al. Among authors: aigner m. Mycoses. 2012 Jan;55(1):27-35. doi: 10.1111/j.1439-0507.2011.02039.x. Epub 2011 Jun 12. Mycoses. 2012. PMID: 21668518 Review.
Treatment of drug-resistant Aspergillus infection.
Aigner M, Lass-Flörl C. Aigner M, et al. Expert Opin Pharmacother. 2015;16(15):2267-70. doi: 10.1517/14656566.2015.1083976. Epub 2015 Sep 2. Expert Opin Pharmacother. 2015. PMID: 26328502
Anidulafungin for the treatment of invasive candidiasis.
Mayr A, Aigner M, Lass-Flörl C. Mayr A, et al. Among authors: aigner m. Clin Microbiol Infect. 2011 Mar;17 Suppl 1:1-12. doi: 10.1111/j.1469-0691.2010.03448.x. Clin Microbiol Infect. 2011. PMID: 21251147 Free article. Review.
Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study.
Auberger J, Lass-Flörl C, Aigner M, Clausen J, Gastl G, Nachbaur D. Auberger J, et al. Among authors: aigner m. J Antimicrob Chemother. 2012 Sep;67(9):2268-73. doi: 10.1093/jac/dks189. Epub 2012 May 30. J Antimicrob Chemother. 2012. PMID: 22653819
196 results